Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:radio_station
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Sr-90
gptkb:yttrium-90 |
| gptkbp:application |
cancer treatment studies
radiopharmaceutical development targeted radionuclide therapy |
| gptkbp:clinical_trial |
treatment of liver cancer
treatment of non-Hodgkin lymphoma |
| gptkbp:collaborations |
clinical trials
pharmaceutical companies medical research institutions |
| gptkbp:composed_of |
alkaline earth metal
|
| gptkbp:discovered_by |
discovery in 1950s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Y-90
|
| gptkbp:isotopes |
gptkb:39
Yttrium beta emitter |
| gptkbp:lifespan |
64.1 hours
|
| gptkbp:marketed_as |
gptkb:SIR-Spheres
gptkb:Thera_Sphere |
| gptkbp:mode |
gptkb:beta_decay
|
| gptkbp:parent |
Zr-90
|
| gptkbp:produced_by |
nuclear reactors
neutron activation |
| gptkbp:regulatory_compliance |
FDA approved
EMA approved |
| gptkbp:safety_features |
radiation exposure
|
| gptkbp:storage |
shielded containers
|
| gptkbp:supply_chain |
gptkb:film_production_company
hospitals academic institutions healthcare providers patient advocacy groups regulatory agencies research organizations distributors insurance providers government health agencies research laboratories biotechnology firms radiation oncologists medical physicists radiation safety officers oncology clinics healthcare administrators healthcare technology companies medical supply companies medical device manufacturers clinical research organizations nuclear engineers clinical trial sponsors medical imaging specialists nuclear medicine technologists radiation therapy centers clinical oncologists nuclear medicine departments nuclear pharmacists patient care organizations pharmaceutical research companies |
| gptkbp:symbol |
Y
|
| gptkbp:used_in |
radioembolization
selective internal radiation therapy |
| gptkbp:uses |
radiotherapy
|